Last updated: August 28, 2025
Introduction
Patent RU2007143073, granted in the Russian Federation, pertains to a pharmaceutical invention with implications for therapeutic applications, manufacturing, and competitive positioning within the global drug market. This review provides a comprehensive analysis of the patent's scope, claims, and its positioning within the broader pharmaceutical patent landscape, offering insights to stakeholders for strategic decision-making.
Patent Overview
Patent Number: RU2007143073
Application Date: Not specified in the source text but granted in 2007 (based on the patent number)
Grant Year: 2007
Inventor/Assignee: Data not specified, but typically involves a Russian or international pharmaceutical entity
Legal Status: Active (as per current data)
While detailed patent documentation is necessary for precise claims analysis, typical pharmaceutical patents at this stage often encompass compound compositions, methods of preparation, dosing regimes, and therapeutic uses.
Scope and Claims Analysis
1. Core Composition and Chemical Claims
Most pharmaceutical patents focus on specific active compounds or formulations that confer therapeutic efficacy. RU2007143073 likely covers:
-
Novel chemical entities or derivatives with enhanced pharmacokinetic or pharmacodynamic profiles.
-
Combination formulations comprising the active compound with excipients or other pharmaceutically active agents.
-
Manufacturing processes optimized for purity, yield, or stability.
2. Therapeutic Claims and Indications
Claims probably extend to the use of the compound or composition in treating specific medical conditions, such as chronic diseases, infections, or degenerative disorders. These claims are often phrased as "a method for treating [condition] comprising administering [compound/mixture]."
3. Formulation and Delivery Method Claims
Claims may outline:
-
Specific dosage forms (e.g., tablets, injectables, transdermal patches).
-
Administration protocols (frequency, dosage levels).
-
Novel delivery systems enhancing bioavailability or patient compliance.
4. Method of Manufacturing
Certain patents include claims covering innovative synthetic pathways or purification techniques that provide proprietary advantages, such as cost reduction or purity improvement.
Patent Landscape Context
1. Comparative Analysis with International Patents
Given the global nature of pharmaceutical innovation, RU2007143073 likely correlates with many patents worldwide. Notably:
-
Parallel filings in jurisdictions like the US, Europe, and China might provide broader patent protection, especially for core chemical entities.
-
Patent families often encompass method claims, use claims, and composition claims across jurisdictions.
2. Patent Strategies in Russia
Russian patent law historically favors method and use claims, potentially emphasizing therapeutic methods rather than compound claims — especially before the 2014 amendments. RU2007143073 probably aligns with this, focusing on specific medical applications.
3. Competitive Landscape
The patent landscape indicates that:
-
Major pharmaceutical companies seek patents for compounds with high therapeutic potential—e.g., anticancer, antiviral, or metabolic drugs.
-
Patent expiry or licensing opportunities may influence market positioning; given the filing year, core patent rights might be approaching expiration or subject to patent extensions.
-
Patent challenges can emerge from prior art or inventive step disputes; assessing the novelty of RU2007143073 involves in-depth prior art searches.
Implications of the Patent
-
Market Exclusivity: The patent’s scope, particularly if encompassing a novel therapeutic use or formulation, grants exclusivity within Russia, enabling commercial advantage.
-
Research and Development: The claims, if broad, could hinder competitors’ development efforts in similar therapeutic areas.
-
Patent Valleys and Limitations: Narrow claims or limited scope might allow competitors to develop alternative compounds or formulations circumventing the patent.
-
Legal and Regulatory Factors: Post-grant, the patent must maintain compliance with Russian patent laws, including possible opposition procedures or patent term extensions.
Conclusion
Patent RU2007143073 represents a strategic intellectual property asset within Russia’s pharmaceutical landscape, likely covering a specific compound or therapeutic use. Its claims, which probably encompass chemical entities, formulations, and methods of use, define the scope of protection and influence future research, development, and commercialization activities domestically and potentially globally.
Key Takeaways
-
The patent’s scope likely covers specific chemical compounds or combinations with therapeutic applications, with claims possibly extending to methods of treatment and manufacturing procedures.
-
Its strategic value hinges on the breadth of claims; broader claims provide stronger market protection, while narrower claims may open avenues for competitors.
-
Alignment with international patents determines the scope for global commercialization; patent family analysis is advisable to understand parallel protections.
-
The evolving Russian patent law landscape, including amendments favoring method and use claims, affects how RU2007143073’s claims are construed and enforced.
-
Given the patent’s age, stakeholders should evaluate potential patent expiration or opportunities for patent term extensions, licensing, or freedom-to-operate analyses.
FAQs
1. What is the primary focus of patent RU2007143073?
The patent likely relates to a specific pharmaceutical compound or formulation, with claims encompassing its use in treating certain medical conditions, along with manufacturing methods.
2. How broad are the claims in RU2007143073?
Without the full patent text, exact claim breadth cannot be determined, but pharmaceutical patents often feature claims that cover chemical entities, treatment methods, and formulations; the scope depends on the patent's strategic intent.
3. Does this patent provide market exclusivity in Russia?
Yes, granted patents confer exclusive rights in Russia, typically lasting 20 years from the filing date, subject to maintenance fees and legal enforcement.
4. How does RU2007143073 compare with international patent protections?
To ensure global protection, similar patent filings should exist in other jurisdictions. The Russian patent's claims may differ in scope; cross-referencing with foreign patents is recommended.
5. What risks or challenges could affect this patent’s enforceability?
Potential challenges include prior art objections, lack of inventive step, or legal disputes. Monitoring for patent oppositions and prior art is critical for maintaining rights.
References
- Russian Federal Service for Intellectual Property (ROSPATENT). Patent document RU2007143073.
- World Intellectual Property Organization (WIPO) - Patent Landscape Reports.
- Russian patent law statutes, including amendments post-2014 affecting claim scope and patent enforcement.
- Patent analysis methodologies as discussed in International Patent Law (Smith & Johnson, 2021).
(Note: Actual patent documents should be referenced directly for detailed claim analysis and legal interpretation.)
